Europe Metagenomics Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Europe Metagenomics Market to 2027 - Regional Analysis and Forecasts by Product (Instruments & Software and Consumables), Application (Clinical Diagnostics, Drug Discovery Metagenomics and Others) and Country

Publication Month: Feb 2019 | Report Code: TIPRE00003321 | No. of Pages: 138 | Category: Biotechnology | Status: Published
The Europe Metagenomics market is expected to reach US$ 89.7 Mn in 2027 from US$ 48.6 Mn in 2018. The market is estimated to grow with a CAGR of 7.4% from 2018-2027.

The growth of the market is driven by the factors such as technological advancements in the metagenomics, growing preference for Metagenomics over traditional methods and wide range metagenomics applications, in the Europe region. Whereas, highly priced metagenomics technology is likely to have a negative impact on the growth of the market in the coming years.

Metagenomics is the upcoming field of the biotechnology and the extensive researches are being conducted in the labs across the world. In addition, the next generation sequencing and other technologies in the genomics are assisting in the conduction of the metagenomics studies. Also, in recent years, next generation sequencing price have declined substantially. For instance, first whole human genome sequencing cost over US$3.7 billion in 2000 and took 13 years for the completion. However, the costs for the same in recent years has reduced to US$1,000 and the process requires less number of days. In 2000, cost for sequencing was US$ 3.7 billion, which dropped down to US$ 10 million in 2006 and declined to US$ 5,000 in 2012. One of the few biotech unicorns in Europe, Oxford Nanopore Technologies based in UK have introduced breakthrough technologies in DNA sequencing. The company has developed handheld MinION sequencer to sequence the human genome. The device was able to read sequences of DNA that are hundreds times larger than usual, helping scientists better reconstruct the whole genome sequence. MinION costs less than $1,000 and offers high-speed sequencing even outside of the lab, with an accuracy of up to 99.96% when using ‘nanopolish’ software to correct any errors made during sequencing.

Owing to factor that the cost of the metagenomics is been subsidize by the venture capitalists and the innovative technology by the market leaders that enables the access to the metagenomics studies are likely to propel the growth of the market in the forecast period.

Germany is measured as the biggest hub for biotechnology in Europe and across the world owing to presence of large biotechnology players, high-tech research labs and massive funding for conduction of research and development. Germany is a country where various biotechnological companies reside than any other countries in Europe. The country is also accounted in the international list of toppers for the number of studies that are in pipeline. The cutting edge and high-quality research present in the country creates lucrative opportunity and presence of an established market for metagenomics.

Exhibit: Rest of Europe Metagenomics Market Revenue and Forecasts to 2027 (US$ Bn)


EUROPE METAGENOMICS - MARKET SEGMENTATION

By Product
  • Instruments & Software
  • Consumables
EUROPE METAGENOMICS - MARKET SEGMENTATION

By Application

  • Clinical Diagnostics
  • Drug Discovery
By Country
  • France
  • Germany
  • U.K.
Companies Mentioned
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies
  • Qiagen
  • Bio-Rad Laboratories, Inc.
  • Perkinelmer Inc.
  • Illumina Inc.
  • F Hoffman-La Roche Ltd.
  • Oxford Nanopore Technologies Ltd.
  • Pacific Bioscience of California, Inc.

PART 1. iNTRODUCTION

1.1    Scope of the Study

1.2    The Insight Partners Research Report Guidance

PART 2. Europe Metagenomics Market – Key takeaways

PART 3. Europe Metagenomics market –  market landscape

3.1    overview

3.2    market segmentation

3.2.1    Europe Metagenomics Market – By Product

3.2.2    Europe Metagenomics Market – By Application

3.2.3    Europe Metagenomics Market – By Country

3.3    PEST Analysis

PART 4. Europe Metagenomics market- Key Market Dynamics

4.1    Key Market Drivers

4.1.1    Technological Advancements in Metagenomics

4.1.2    Growing Preference for Metagenomics Over Traditional Methods

4.1.3    Wide Range of  Metagenomics Applications

4.2    Key Market Restraints

4.2.1    Highly Priced Metagenomics Technology

4.3    Key Market Opportunities

4.3.1    Precision Metagenomic Analysis- Ushering In The Era Of Precision Medicine

4.4    Key Market Trends

4.4.1    Increasing Inclination towards Molecular-Based Approaches

4.5    Impact analysis

PART 5. Metagenomics market – Europe Analysis

5.1    Europe Metagenomics market Revenue Forecasts and Analysis

5.2    Market positioning

5.3    PERFORMANCE OF KEY PLAYERS

Illumina, Inc.

Qiagen

5.4    expert opinions

PART 6. Europe Metagenomics market Analysis –  By Product

6.1    Overview

6.2    EUROPE metagenomics MARKET, BY product, 2018 & 2027 (%)

6.3    Europe Metagenomics market Revenue And Forecasts to 2027, By Product (US$ Mn)

6.4    Instruments & Software Market

6.4.1    Overview

6.4.2    Europe Instruments & Software Market Revenue and Forecasts to 2027 (US$ Mn)

6.5    Consumables Market

6.5.1    Overview

6.5.2    Europe Consumables Market Revenue and Forecasts to 2027 (US$ Mn)

PART 7. Europe Metagenomics market Analysis –  By Application

7.1    Overview

7.2    EUROPE Metagenomics MARKET, BY application, 2018 & 2027 (%)

7.3    Europe Metagenomics market Revenue And Forecasts to 2027, By Application (US$ Mn)

7.4    Clinical Diagnostic Market

7.4.1    Overview

7.4.2    Europe Clinical Diagnostic Market Revenue and Forecasts to 2027 (US$ Mn)

7.5    Drug Discovery metagenomics Market

7.5.1    Overview

7.5.2    Europe Drug Discovery Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)

7.6    Others Market

7.6.1    Overview

7.6.2    Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)

PART 8. Europe Metagenomics market Revenue and Forecasts  to 2027

8.1    Overview

8.2    Europe Metagenomics Market Revenue And Forecasts to 2027, By Country (%)

8.3    UK Metagenomics market Revenue and Forecasts to 2027 (US$ Mn)

8.3.1    UK Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)

8.3.2    UK Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

8.3.3    UK Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)

8.4    Germany Metagenomics market Revenue and Forecasts to 2027 (US$ Mn)

8.4.1    Germany Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)

8.4.2    Germany Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

8.4.3    Germany Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)

8.5    France Metagenomics market Revenue and Forecasts to 2027 (US$ Mn)

8.5.1    France Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)

8.5.2    France Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

8.5.3    France Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)

PART 9. Metagenomics Market –Industry Landscape

9.1    Overview

9.2    Growth Strategies in the Metagenomics Market, 2015-2018

9.3    Organic Developments

9.3.1    Overview

9.4    Organic Growth Strategies in the METAGENOMICS Market, 2015-2018

9.5    Product Launch

9.5.1    Recent Product Launch By Players In The Metagenomics Market

9.6    Product approval

9.6.1    Recent Product Approval By Players In The Metagenomics Market

9.7    Expansion & Others

9.7.1    The Metagenomics Market By Expansion & Other Growth Strategies

9.8    Inorganic developments

9.8.1    Overview

9.9    inOrganic Growth Strategies in the Metagenomics Market, 2015-2018

9.10   Acquisitions

9.10.1 Acquisitions By Players In The Metagenomics Market

9.11   Agreements

9.11.1 The Metagenomics Market By Agreements

9.12   Partnership & Collaboration

9.12.1 Partnership By Players In The Metagenomics Market

PART 10. Metagenomics Market–Key company profiles

10.1   Merck KGaA

10.1.1  Key Facts

10.1.2  Business Description

10.1.3  Financial Overview

10.1.4  Product Portfolio

10.1.5  SWOT Analysis

10.1.6  Key Developments

10.2   Thermo Fisher Scientific, Inc.

10.2.1  Key Facts

10.2.2  Business Description

10.2.3  Financial Information

10.2.4  Product Portfolio

10.2.5  SWOT Analysis

10.2.6  Key Developments

10.3   Agilent Technologies, Inc.

10.3.1  Key Facts

10.3.2  Business Description

10.3.3  Financial Overview

10.3.4  Product Portfolio

10.3.5  SWOT Analysis

10.3.6  Key Developments

10.4   QIAGEN

10.4.1  Key Facts

10.4.2  Business Description

10.4.3  Financial Overview

10.4.4  Product Portfolio

10.4.5  SWOT Analysis

10.4.6  Key Developments

10.5   Bio-Rad Laboratories, Inc.

10.5.1  Key Facts

10.5.2  Business Description

10.5.3  Financial Information

10.5.4  Product Portfolio

10.5.5  SWOT Analysis

10.5.6  Key Developments

10.6   Perkin Elmer, inc.

10.6.1  Key Facts

10.6.2  Business Description

10.6.3  Financial Overview

10.6.4  Product Portfolio

10.6.5  SWOT Analysis

10.6.6  Key Developments

10.7   Illumina, Inc.

10.7.1  Key Facts

10.7.2  Business Description

10.7.3  Financial Overview

10.7.4  Product Portfolio

10.7.5  SWOT Analysis

10.7.6  Key Developments

10.8   F. Hoffmann-La Roche Ltd.

10.8.1  Key Facts

10.8.2  Business Description

10.8.3  Financial Overview

10.8.4  Product Portfolio

10.8.5  SWOT Analysis

10.8.6  Key Developments

10.9   Oxford Nanopore Technologies Ltd.

10.9.1  Key Facts

10.9.2  Business Description

10.9.3  Financial Overview

10.9.4  Product & Services Portfolio

10.9.5  SWOT Analysis

10.9.6  Key Developments

10.10 Pacific Bioscience of California, inc.

10.10.1 Key Facts

10.10.2 Business Description

10.10.3 Financial Overview

10.10.4 Product & Services Portfolio

10.10.5 SWOT Analysis

10.10.6 Key Developments

PART 11.  Appendix

11.1   About The Insight Partners

11.2   Glossary of Terms

11.3   Methodology

11.3.1  Coverage

11.3.2  Secondary Research

11.3.3  Primary Research

 

LIST OF TABLES

TABLE 1.       Europe Metagenomics market Revenue And Forecasts to 2025, By product (US$ Mn)

TABLE 2.       Europe Metagenomics market Revenue And Forecasts to 2025, By application (US$ Mn)

TABLE 3.       UK Metagenomics market Revenue And Forecasts to 2027, By Product (US$ Mn)

TABLE 4.       UK Metagenomics market Revenue And Forecasts to 2025, By application (US$ Mn)

TABLE 5.       Germany Metagenomics market Revenue And Forecasts to 2027, By Product (US$ Mn)

TABLE 6.       Germany Metagenomics market Revenue And Forecasts to 2025, By application (US$ Mn)

TABLE 7.       France Metagenomics market Revenue And Forecasts to 2027, By Product (US$ Mn)

TABLE 8.       France Metagenomics market Revenue And Forecasts to 2025, By application (US$ Mn)

TABLE 9.       Recent Product Launch in the Metagenomics Market

TABLE 10.      Recent Product Approval and Enhancements in the Metagenomics Market

TABLE 11.      the Metagenomics Market by Exansion & Others Strategies

TABLE 12.      Acquisitions in the Metagenomics Market

TABLE 13.      the Metagenomics Market by Agreements

TABLE 14.      partnership in the Metagenomics Market

TABLE 15.      Glossary of Terms, Metagenomics market

 

LIST OF FIGURES

FIGURE 1.      GErmany Metagenomics market, Revenue (US$ Mn), By 2018 & 2027

FIGURE 2.      Europe Metagenomics Market By product, Market Share (%), 2018

FIGURE 3.      Europe Metagenomics Market By application, Market Share (%), 2018

FIGURE 4.      Metagenomics market Segmentation

FIGURE 5.      Europe PEST Analysis

FIGURE 6.      Metagenomics market impact analysis of drivers & Restraints

FIGURE 7.      Europe Metagenomics market – Revenue Forecasts and Analysis – 2017- 2027

FIGURE 8.      Europe metagenomics market By Product, 2018 & 2027 (%)

FIGURE 9.      Europe Instruments & software Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 10.    Europe Consumables Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 11.    Europe Metagenomics market By application, 2018 & 2027 (%)

FIGURE 12.    Europe Clinical Diagnostic Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 13.    Europe Drug Discovery Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 14.    Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 15.    Europe Metagenomics Market REVENUE, by Country, 2018 (US$ MN)

FIGURE 16.    Europe metagenomics Market Revenue And Forecasts to 2027, By Country (%)

FIGURE 17.    UK Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 18.    Germany Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 19.    France Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 20.    Growth Strategies in the Metagenomics Market, 2015-2018

FIGURE 21.    Organic Growth Strategies in the METAGENOMICS Market, 2015-2018

FIGURE 22.    Inorganic developments in the Metagenomics Market, 2015-2018

The List of Companies

  1. Merck KGaA
  2. Thermo Fisher Scientific Inc.
  3. Agilent Technologies
  4. Qiagen
  5. Bio-Rad Laboratories, Inc.
  6. Perkinelmer Inc.
  7. Illumina Inc.
  8. F Hoffman-La Roche Ltd.
  9. Oxford Nanopore Technologies Ltd.
  10. Pacific Bioscience of California, Inc.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the metagenomics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global metagenomics market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Select License Type
USD $2000
USD $3000
USD $4000
USD $5000